Hysteroscopic Surgery
Conditions
Interventions
Group N1:Nalbuphine 0.1 mg/kg was administered intravenously prior to anesthesia induction.
Group N2:Nalbuphine 0.2 mg/kg was administered intravenously prior to anesthesia induction.
Group N3:Nalbuphine 0.4 mg/kg was administered intravenously prior to anesthesia induction.
Group C:An equivalent volume of normal saline was administered intravenously prior to anesthesia induction.
Sponsors
Guangyuan Central Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria were as follows: patients scheduled for diagnostic or operative hysteroscopy, age range 20–45 years, ASA classification I–II.
Exclusion criteria
Exclusion criteria: 1. BMI >30 or <18 kg/m^2; 2. Refusal to sign the informed consent for the trial or inability to communicate; 3. Recent use of analgesics or sedatives, history of chronic pain, psychiatric disorders, alcohol or drug abuse; 4. Family history of malignant hyperthermia; 5. Patients allergic to opioids or inhalation anesthetics; 6. Patients with liver or kidney dysfunction; 7. Patients who have had vaginal delivery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| minimum alveolar concentration; | — |
Secondary
| Measure | Time frame |
|---|---|
| HR, MAP, BIS;Anesthesia Recovery Time ;Laryngeal Mask Airway (LMA) Removal Time;Aldrete Post-Anesthesia Recovery Score;Sedation-Agitation Scale Score;Face, Legs, Activity, Cry, Consolability Behavioral Pain Scale Score;Cumulative doses of propofol and sufentanil;Incidence of Adverse Events; | — |
Countries
China
Contacts
Public ContactZhou Tao
Guangyuan Central Hospital
Outcome results
None listed